Drug class · Oncology & immunology
Kinase inhibitors Drug Codes & NDCs
Small-molecule drugs that inhibit one or more protein kinases. Most are oral products dispensed by pharmacies.
FDA-listed products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| nintedanib | Nintedanib esylate 100 mg/1 | CapsuleOral | Sandoz Inc | 0781-2492 |
| nintedanib | Nintedanib esylate 150 mg/1 | CapsuleOral | Sandoz Inc | 0781-2495 |
| Nintedanib | Nintedanib esylate 100 mg/1 | CapsuleOral | Edenbridge Pharmaceuticals LLC. | 42799-972 |
| Nintedanib | Nintedanib esylate 150 mg/1 | CapsuleOral | Edenbridge Pharmaceuticals LLC. | 42799-973 |
| nintedanib | Nintedanib esylate 150 mg/1 | CapsuleOral | EPIC PHARMA LLC | 42806-568 |
| nintedanib | Nintedanib esylate 100 mg/1 | CapsuleOral | EPIC PHARMA LLC | 42806-569 |
| Nintedanib | Nintedanib esylate 150 mg/1 | CapsuleOral | Dr. Reddy's Laboratories Inc. | 43598-147 |
| Nintedanib | Nintedanib esylate 100 mg/1 | CapsuleOral | Dr. Reddy's Laboratories Inc. | 43598-148 |
| Nintedanib | Nintedanib esylate 100 mg/1 | CapsuleOral | Golden State Medical Supply, Inc. | 51407-984 |
| Nintedanib | Nintedanib esylate 150 mg/1 | CapsuleOral | Golden State Medical Supply, Inc. | 51407-985 |
| Nintedanib | Nintedanib esylate 100 mg/1 | CapsuleOral | Apotex Corp. | 60505-4818 |
| Nintedanib | Nintedanib esylate 150 mg/1 | CapsuleOral | Apotex Corp. | 60505-4819 |
| nintedanib | Nintedanib esylate 100 mg/1 | CapsuleOral | Glenmark Pharmaceuticals Inc., USA | 68462-802 |
| nintedanib | Nintedanib esylate 150 mg/1 | CapsuleOral | Glenmark Pharmaceuticals Inc., USA | 68462-803 |
| Nintedanib | Nintedanib esylate 150 mg/1 | CapsuleOral | Cipla USA Inc. | 69097-639 |
| Nintedanib | Nintedanib esylate 100 mg/1 | CapsuleOral | Cipla USA Inc. | 69097-641 |
| nintedanib | Nintedanib esylate 100 mg/1 | CapsuleOral | AvKARE | 73190-096 |
| nintedanib | Nintedanib esylate 150 mg/1 | CapsuleOral | AvKARE | 73190-097 |
| Nintedanib Capsules, 100 mg and 150 mgnintedanib | Nintedanib esylate 100 mg/1 | CapsuleOral | EXELAN PHARMACEUTICALS INC. | 76282-786 |
| Nintedanib Capsules, 100 mg and 150 mgnintedanib | Nintedanib esylate 150 mg/1 | CapsuleOral | EXELAN PHARMACEUTICALS INC. | 76282-787 |
| Nintedanib esylate | Nintedanib esylate 100 mg/1 | CapsuleOral | Macleods Pharmaceuticals Limited | 33342-550 |
| Nintedanib esylate | Nintedanib esylate 150 mg/1 | CapsuleOral | Macleods Pharmaceuticals Limited | 33342-551 |
| Ofevnintedanib | Nintedanib esylate 100 mg/1 | CapsuleOral | Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-0143 |
| Ofevnintedanib | Nintedanib esylate 150 mg/1 | CapsuleOral | Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-0145 |
| Ojemdatovorafenib | Tovorafenib 100 mg/1 | Tablet, Film coatedOral | Day One Biopharmaceuticals, Inc. | 82950-001 |